Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CNI stock price vs BNTX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BNTX's multiple
Needs Annual EPS, BNTX P/E.
Implied fair value · at CNI's multiple
Needs Annual EPS is negative, CNI P/E.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CNI Latest annual filing · BNTX FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CANADIAN NATIONAL RAILWAY CO · implied price per share
The ordinary-share to listed-security ratio could not be verified.
BioNTech SE · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Net debt / EBITDA
Leverage against operating earnings
—
4.45x
Cash and equivalents
Liquid reserves on the balance sheet
—
$7.68B
Total debt
Interest-bearing obligations outstanding
—
$2.68B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
UNION PACIFIC CORP
CNI vs UNP
CSX CORP
CNI vs CSX
NORFOLK SOUTHERN CORP
CNI vs NSC
CANADIAN PACIFIC KANSAS CITY LTD/CN
CNI vs CP
Moderna, Inc.
CNI vs MRNA
GILEAD SCIENCES, INC.
CNI vs GILD
AMGEN INC
CNI vs AMGN
REGENERON PHARMACEUTICALS, INC.
CNI vs REGN
INCYTE CORP
CNI vs INCY
VERTEX PHARMACEUTICALS INC / MA
CNI vs VRTX
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
